Queen Mary Innovation
At QMI we protect and license intellectual property and build sustainable spinouts and social ventures that turn Queen Mary research into impact.
Raising investment
Procyon
Biomarker technologies for early cancer detection
CE-Track
A wearable antenna-based system with advanced sensing, machine learning and AI locate and track a capsule endoscope for fast and accurate diagnosis.
ReFleks
A pioneering regenerative therapy to repair joint damage, treat osteoarthritis, and provide lasting pain relief.
EcoBarrier
EcoBarrier is a superhydrophobic coating for use in food and drinks packaging which is far superior to conventional waterproofing.
SynTex
A new material for synthetic heart valves which will enable patients to live lives indistinguishable from having a healthy heart.
Nilocas
Nilocas Ltd is developing a medical device to revolutionise the detection of Coronary Artery Disease.
AeroSolar
A new method to improve manufacturing of perovskite solar panels.
Nattüra
Nattüra offers 24-hour dental protection by creating a bio-shield that stays on your enamel long after you stop brushing.
Nemisindo
Generating unique sound effects in real time using AI.
Kinomica
A diagnostic platform to help clinicians prescribe the right drug, for the right patient, at the right time.
Newrotex
Newrotex are using spider silk to create surgical devices for nerve regeneration. Spider silk acts like a scaffold for nerves to grow along.
Technology highlights
Predicting patient response to arthritis treatment
The method uses deep molecular phenotyping and machine learning on a small biopsy taken from the patient’s joints.
Digital Twin of the Aorta
TAVR-AID is a digital twin of the aorta specific to each patient, which simulates blood flow and makes predictions using artificial intelligence.
Predicting Pre-Eclampsia
A new blood test for predicting pre-eclampsia just five to sixteen weeks into a pregnancy.
Predicting dementia nine years before symptoms
A new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis.
Enhancing the efficacy of immunotherapy in lung cancer
A new methodology for treating lung cancer – the leading cause of cancer deaths worldwide.
Single molecule biochips
Life-saving portable nanoscale biochips which can diagnose patients in real time so clinicians can intervene immediately to improve blood clotting and prevent fatal bleeding.
A Rapid PCR Test for Early Cancer Diagnosis
A qPCR-based diagnostic test for detecting oral cancer risk and predicting patient prognosis.
A Peptide Therapy for Neovascular Eye Diseases
Angiogenesis is a leading cause of eye problems among over 50s – including blindness.
Latest news and opportunities
Contact QMI
Learn more about our technologies from the relevant expert.